SLNO has been in the news 750% more than usual
Nov 07, 2025, 1:32 AM
17.99%
What does SLNO do
Soleno Therapeutics, a clinical-stage biopharmaceutical company based in Redwood City, California, focuses on developing novel therapeutics for rare diseases, notably DCCR for Prader-Willi syndrome. DCCR, a once-daily oral tablet, recently completed Phase 3 trials and has received Fast-Track and orphan designations in the U.S. and EU.
SLNO has been in the news recently: Soleno Therapeutics reported a 15% increase in revenue this quarter, largely due to strong sales from their new product line. The company's improved market presence contributed to this positive financial performance.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.